Price (delayed)
$1.44
Market cap
$72.2M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3
Enterprise value
-$59.38M
Highlights
HLVX's debt has dropped by 52% year-on-year
HLVX's EPS is up by 3.2% since the previous quarter
HilleVax's net income has decreased by 19% YoY but it has increased by 2% QoQ
The equity has declined by 42% year-on-year and by 16% since the previous quarter
HLVX's quick ratio is down by 24% since the previous quarter
Key stats
What are the main financial stats of HLVX
MarketValuationsEarnings
Shares outstanding
50.14M
Market cap
$72.2M
Enterprise value
-$59.38M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.46
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$155.29M
Net income
-$147.27M
EBIT
-$143.95M
EBITDA
-$140.75M
Free cash flow
-$109.31M
Per shareBalance sheetLiquidity
EPS
-$3
EPS diluted
-$3
Free cash flow per share
-$2.22
Book value per share
$3.1
Revenue per share
$0
TBVPS
$3.92
Total assets
$192.69M
Total liabilities
$38.2M
Debt
$24.51M
Equity
$154.49M
Working capital
$161.89M
Debt to equity
0.16
Current ratio
10.84
Quick ratio
10.52
Net debt/EBITDA
0.93
MarginsEfficiencyDividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-58.6%
Return on equity
-75.3%
Return on invested capital
-107.3%
Return on capital employed
-81.7%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HLVX stock price
How has the HilleVax stock price performed over time
Intraday
-0.69%
1 week
-9.43%
1 month
-19.1%
1 year
-90.07%
YTD
-30.43%
QTD
-0.69%
Financial performance
How have HilleVax's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$155.29M
Net income
-$147.27M
Gross margin
N/A
Net margin
N/A
HLVX financials
HilleVax's net income has decreased by 19% YoY but it has increased by 2% QoQ
HilleVax's operating income has decreased by 16% YoY but it has increased by 2.6% QoQ
Growth
What is HilleVax's growth rate over time
HLVX growth chart
Valuation
What is HilleVax stock price valuation
P/E
N/A
P/B
0.46
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Price to earnings (P/E)
HLVX's EPS is up by 3.2% since the previous quarter
Price to book (P/B)
HLVX's price to book (P/B) is 77% less than its last 4 quarters average of 2.0
The equity has declined by 42% year-on-year and by 16% since the previous quarter
Price to sales (P/S)
Efficiency
How efficient is HilleVax business performance
HilleVax's ROE has plunged by 56% YoY and by 12% from the previous quarter
The return on assets has dropped by 54% year-on-year and by 13% since the previous quarter
The ROIC has contracted by 22% YoY and by 17% from the previous quarter
Dividends
What is HLVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HLVX.
Financial health
How did HilleVax financials performed over time
Assets vs liabilities
The total liabilities has plunged by 52% YoY but it has grown by 5% from the previous quarter
HLVX's total assets is down by 44% year-on-year and by 13% since the previous quarter
Debt vs equity
HLVX's debt is 84% smaller than its equity
HLVX's debt has dropped by 52% year-on-year
The equity has declined by 42% year-on-year and by 16% since the previous quarter
Balance sheet
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from 
and Sharadar.